Document is current
Any future updates will be listed below
-
Authors
Antoine, Alison
Desroziers, Katia
Dupin, Julien
Pérol, David
Choquet, Rémy
-
Funding
Funding for this research was provided by:
Roche
National French Research and Technology Association (CIFRE doctoral fellowship no. 2020/1054)
- License Information
-
More Information
Article History
Received: 18 March 2024
Accepted: 16 September 2025
First Online: 3 November 2025
Declarations
:
: Not applicable.
: Not applicable.
: AA, KD and RC are currently employed by Roche which participated in the study’s design, data collection, analysis, interpretation, and manuscript writing. AA reports a grant from the National French Research and Technology Association (ANRT) and Roche (France) via CIFRE doctoral fellowship no. 2020/1054. JD was employed by Roche at the time of the study and is currently employed by J&J Innovative medicine. DP reports personal fees and travel funding from Roche and Novartis; consulting and personal fees from Brenus Pharma, Gilead and Takeda; personal fees from AstraZeneca, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, Eli-Lilly, Merck Sharp and Dohme, and Pfizer, outside the submitted work.
